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Experimental values of permeability coefficients, as log Kp, of chemical compounds across 
human skin were collected by carefully screening the literature, and adjusted to 37 ℃ for the 
effect of temperature. The values of log Kp for partially ionized acids and bases were separated 
into those for their neutral and ionic species, forming a total data set of 247 compounds and 
species (including 35 ionic species). The obtained log Kp values have been regressed against 
Abraham solute descriptors to yield a correlation equation with R2 = 0.866 and SD = 0.432 log 
units. The equation can provide valid predictions for log Kp of neutral molecules, ions and 
ionic species, with predictive R2 = 0.858 and predictive SD = 0.445 log units calculated by the 
leave-one-out statistics. The predicted log Kp values for Na+ and Et4N+ are in good agreement 
with the observed values. We calculated the values of log Kp of ketoprofen as a function of 
the pH of the donor solution, and found that log Kp markedly varies only when ketoprofen is 
largely ionized. This explains why models that neglect ionization of permeants still yield 
reasonable statistical results. The effect of skin thickness on log Kp was investigated by 
inclusion of two indicator variables, one for intermediate thickness skin and one for full 
thickness skin, into the above equation. The newly obtained equations were found to be 
statistically very close to the above equation. Therefore, the thickness of human skin used 
makes little difference to the experimental values of log Kp. 
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Rapid and accurate prediction of human skin permeability of chemical compounds is very 
useful for developing dermal and transdermal drug delivery systems and cosmetics, as well 
as evaluating environmental risks due to contact with skin. Various kinds of empirical and 
mathematical models for the correlation and prediction of human skin permeability, as log 
Kp, have been reported (Baba et al., 2015; Mitragotri, 2003), and there have been a number 
of reviews of these models (Chen et al., 2013; Geinoz et al., 2004; Mitragotri et al., 2011; Moss 
et al., 2011; Neely et al., 2009). It has been known for years that the permeability of ionizable 
compounds depends on the pH of the donor solution, attributed to the slower rate of 
permeation of ionic species compared to the corresponding neutral species (Roy and Flynn, 
1990; Swarbrick et al., 1984; Waters and Bhuiyan, 2016). For instance, Waters and Bhuiyan 
(2016)  recently reported that as an in vitro skin mimic, silicone membrane encouraged 
permeation of the more unionized forms of pharmaceutical compounds rather than the 
ionized forms. However, the above reviews completely ignore the possibility of ionization and 
associated factors such as the dependence of permeation on pH for ionizable compounds, 
and our previous study represents the only attempt to include ionized species in a model for 
skin permeation (Zhang et al., 2012). Thus one of the most popular models for skin 
permeation, the Potts and Guy model (Potts and Guy, 1992), uses only the octanol-water 
partition coefficient (as log Po/w) and molecular weight (MW) as compound descriptors (see 
Eq. 1), with no reference to ionic species.  
p o/wlog K 0.71log P - 0.0061MW - 6.3           (1) 
As mentioned, we have previously constructed an equation for predicting skin permeability 
of neutral molecules, ions and ionic species using the Abraham linear free-energy relationship 
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(LFER) model (Zhang et al., 2012). Since then, descriptors for considerably more compounds 
have been obtained, including those for ionic species (Abraham and Acree, 2016), and it is the 
purpose of the present work to set out an extended equation for the correlation and 
prediction of human skin permeability, including neutral molecules and ionic species in the 
same equation.  
METHODS 
LFER model 
Our method is based on the LFER method of Abraham, firstly applied to the properties of 
neutral molecules (Abraham, 1993) and subsequently extended to include ions and ionic 
species by Abraham and Acree (Abraham, 2011; Abraham and Acree, 2010a, b, 2016). The 
general equation developed by Abraham and Acree is stated as: 
SP = c + eE + sS + aA + bB + vV + j+J+ + j−J−      (2) 
The dependent variable SP represents an equilibrium coefficient for a series of solutes in a 
given system, including partition coefficients (as log P) and rate coefficients (as log K), and in 
the present work permeation coefficients through human skin, as log Kp. The independent 
variables are the physicochemical properties or descriptors of the solutes as follows. E is the 
excess molar refraction in units of (cm3/mol)/10, S is the combined dipolarity/polarizability, A 
and B are the overall solute hydrogen bond acidity and basicity, and V is McGowan’s 
characteristic molecular volume in units of (cm3/mol)/100; J+ and J- are the additional 
descriptors that are specific to ionic species. Note that J+ = 0 for anions, J− = 0 for cations, and 
both J+ and J− = 0 for neutral molecules. In the latter case, Eq. 2 reduces to an equation for 
neutral molecules. We use the term “ions” for permanent ions such as Na+ and Cl−, and the 
term “ionic species” for ions derived from protonation of basic compounds and deprotonation 
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of acidic compounds. The compound descriptors for neutral molecules are obtained from a 
variety of experimental processes, as explained in a number of reviews (Abraham et al., 2004; 
Clarke and Mallon, 2012; Poole et al., 2013), and Abraham and Acree have reviewed the 
methods used to obtain descriptors for ions and ionic species (Abraham and Acree, 2016). The 
coefficients (c, e, s, a, b, v, j+ and j-) in Eq. 2 can be obtained by a multiple linear regression of 
values of SP in a given system against the known solute descriptors, and used to characterize 
the system of interest. 
  
Effect of Temperature and Ionization  
The reliability of the predictive model greatly depends upon the quality of the used database. 
In this study, we ensured that measurements for the selected Kp data were rigorously 
conducted through in vitro passive diffusion study across excised human skin. As regards the 
influence of temperature, we corrected values of log Kp at various temperatures to obtain the 
corresponding value at 37 ℃ as detailed by Abraham and Martins (2004) (see Table 1). The 
determination of these corrections was quite coarse and also they should theoretically vary 
with lipophilicity, but since they are comparatively small little error will be involved in just 
using the corrections in Table 1. 
Table 1. Corrections to log Kp from experimental temperature to 37   
Adjusted temperatures Corrections to log Kp 
from 20   to 37   0.69 
from 25   to 37   0.48 
from 30   to 37   0.28 
from 32   to 37   0.20 




        The effect of ionization on skin permeation of compounds must be taken into 
consideration, Kp for neutral forms being much larger than that for ionic forms (Zhang et al., 
2012). Thus the fractions of neutral and ionic forms (Fn and Fi) for each ionizable compound 
were carefully calculated according to the pH of the donor solution used. As for the donor 
solvent containing no buffer salt, the degree of ionization was derived from pKa and 
concentration of solute. With compounds that are partially ionized/neutral and have known 
values of the fraction ionized and neutral, Fi and Fn, we separate the experimental (total) value 
of Kp(t) into Kp(n) for neutral and Kp(i) for ionic species through the equation 
 
                                                   Kp(t) = Kp(n) × Fn + Kp(i) × Fi                                           (3) 
 
Then we estimate Kp(n) and Kp(i) using our previously established LFER equation (Zhang et al., 
2012) and the neutral and ionic descriptors, and can obtain an approximation of the ratio 
Kp(n)/Kp(i). From Kp(n)/Kp(i) and the accurate values of Fi and Fn, the values of Kp(n) and Kp(i) 
of partially ionized compounds are deduced. These values are included in Table 2. 
RESULTS AND DISCUSSION 
We surveyed the literature and collected in vitro log Kp data of compounds recently measured, 
especially compounds that were ionized under the experimental conditions. As the major 
data sources, our previous dataset (Zhang et al., 2012) and the dataset of Baba et al. (2015). 
were combined in the present work. For compounds that exist in both datasets, we took the 
log Kp values in our previous dataset. This is because most of our log Kp values were derived 
from Abraham and Martins (2004), who had adjusted log Kp for ionization and temperature 
dependence, and had used the mean of the values where multiple values exist. Some 
compounds were omitted in the following cases: a) the compounds are zwitterions under 
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original experimental conditions and b) their descriptors cannot be obtained from the 
experimental data listed in the current literature. We also used compounds whose log Kp had 
been measured by ourselves under reliable experimental conditions. Descriptors for all the 
neutral compounds and ionic species that we considered are listed in Table 2, together with 
the corresponding values of log Kp, corrected to 37 ℃. The values of log Kp of the 247 
compounds or species in our data set covers both ‘highly permeable’ and ‘poorly permeable’ 
values, varying from -10.01 to -3.00, and meets a normal distribution very well, with a mean 
of -6.027 and a standard deviation of 1.165, as seen in Figure 1. 
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Table 2. Compounds and species used in this work, their solute descriptors, observed log Kp values, and log Kp values calculated from Eq. 6 a 




1 1,1-dichloropropanone 0.395 0.73 0.09 0.35 0.7918 0.0000 0.0000 1.0 0.0 -5.03 -4.83 Baba et al., 2015 
2 1-hexyl-2-pyrrolidone 0.407 1.05 0.00 0.75 1.5245 0.0000 0.0000 1.0 0.0 -5.21 -4.99 Baba et al., 2015 
3 1-methoxy-2-propanol 0.218 0.53 0.33 0.81 0.7896 0.0000 0.0000 1.0 0.0 -6.20 -6.28 Baba et al., 2015 
4 1-octyl-2-pyrrolidone 0.390 1.05 0.00 0.75 1.8063 0.0000 0.0000 1.0 0.0 -4.83 -4.48 Baba et al., 2015 
5 2,4,6-trichlorophenol 1.010 0.80 0.60 0.15 1.1423 0.0000 0.0000 1.0 0.0 -4.30 -4.19 Baba et al., 2015 
6 2,4-dichlorophenol 0.960 0.82 0.54 0.17 1.0199 0.0000 0.0000 1.0 0.0 -4.30 -4.45 Baba et al., 2015 
7 2-amino-4-nitrophenol 1.415 1.95 1.01 0.43 1.0491 0.0000 0.0000 1.0 0.0 -6.54 -5.81 Baba et al., 2015 
8 2-chlorophenol 0.853 0.88 0.32 0.31 0.8975 0.0000 0.0000 1.0 0.0 -4.56 -4.99 Zhang et al., 2012 
9 2-ethoxyethanol 0.237 0.55 0.29 0.82 0.7896 0.0000 0.0000 1.0 0.0 -6.68 -6.30 Zhang et al., 2012 
10 2-hydroxypropyl nicotinate 0.840 1.38 0.35 1.19 1.3720 0.0000 0.0000 1.0 0.0 -7.55 -6.59 Zhang et al., 2012 
11 2-naphthol 1.520 1.08 0.61 0.40 1.1441 0.0000 0.0000 1.0 0.0 -4.65 -4.89 Zhang et al., 2012 
12 2-nitro-p-phenylenediamine 1.525 2.05 0.35 0.70 1.0902 0.0000 0.0000 1.0 0.0 -6.66 -6.21 Baba et al., 2015 
13 2-phenylethanol 0.811 0.82 0.31 0.66 1.0569 0.0000 0.0000 1.0 0.0 -5.20 -5.52 Zhang et al., 2012 
14 3,4-xylenol 0.830 0.90 0.55 0.38 1.0569 0.0000 0.0000 1.0 0.0 -4.52 -4.97 Zhang et al., 2012 
15 3-methylphenol 0.822 0.88 0.57 0.34 0.9160 0.0000 0.0000 1.0 0.0 -4.89 -5.12 Zhang et al., 2012 
16 3-nitrophenol 1.050 1.57 0.79 0.23 0.9493 0.0000 0.0000 1.0 0.0 -5.33 -5.25 Baba et al., 2015 
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17 4-amino-2-nitrophenol 1.360 1.50 0.30 0.66 1.0491 0.0000 0.0000 1.0 0.0 -5.91 -5.87 Baba et al., 2015 
18 4-bromophenol 1.080 1.17 0.67 0.20 0.9501 0.0000 0.0000 1.0 0.0 -4.52 -4.89 Zhang et al., 2012 
19 4-butylphenol 0.796 0.88 0.55 0.37 1.3387 0.0000 0.0000 1.0 0.0 -4.47 -4.43 Baba et al., 2015 
20 4-chloro-3,5-dimethylphenol 0.925 0.96 0.64 0.21 1.1793 0.0000 0.0000 1.0 0.0 -4.31 -4.39 Zhang et al., 2012 
21 4-chloro-3-methylphenol 0.920 1.02 0.67 0.22 1.0384 0.0000 0.0000 1.0 0.0 -4.34 -4.71 Zhang et al., 2012 
22 4-chloro-m-phenylenediamine 1.358 1.50 0.23 0.69 1.0384 0.0000 0.0000 1.0 0.0 -6.54 -5.93 Zhang et al., 2012 
23 4-chlorophenol 0.915 1.08 0.67 0.20 0.8975 0.0000 0.0000 1.0 0.0 -4.52 -4.95 Zhang et al., 2012 
24 4-cyanophenol 0.940 1.63 0.80 0.29 0.9298 0.0000 0.0000 1.0 0.0 -5.53 -5.49 Baba et al., 2015 
25 4-ethylphenol 0.800 0.90 0.55 0.36 1.0569 0.0000 0.0000 1.0 0.0 -4.53 -4.92 Zhang et al., 2012 
26 4-hydroxybenzyl alcohol 0.998 1.30 0.86 0.79 0.9747 0.0000 0.0000 0.0 0.0 -6.26 -6.43 Zhang et al., 2012 
27 4-hydroxy-methylphenylacetate 0.908 1.46 0.59 0.68 1.2722 0.0000 0.0000 1.0 0.0 -5.26 -5.65 Zhang et al., 2012 
28 4-hydroxyphenylacetamide 1.180 2.08 0.84 0.94 1.1724 0.0000 0.0000 0.0 0.0 -6.89 -6.88 Zhang et al., 2012 
29 4-hydroxyphenylacetic acid 1.030 1.45 0.94 0.74 1.1313 0.0000 0.0000 0.0 0.0 -6.16 -6.14 Baba et al., 2015 
30 4-MeC6H4CH2NH(CH2)4Me, cation 0.610 2.60 1.34 0.00 1.8240 1.3136 0.0000 1.0 0.0 -5.80 -5.94 Zhang et al., 2012 
31 4-MeC6H4CH2NH(CH2)5Me, cation  0.600 2.60 1.36 0.00 1.9649 1.2956 0.0000 1.0 0.0 -5.67 -5.67 Zhang et al., 2012 
32 4-MeC6H4CH2NH(CH2)6Me, cation  0.590 2.63 1.36 0.00 2.1058 1.2969 0.0000 1.0 0.0 -5.50 -5.43 Zhang et al., 2012 
33 4-MeC6H4CH2NHBu, cation 0.620 2.62 1.34 0.00 1.6831 1.3349 0.0000 1.0 0.0 -6.52 -6.23 Zhang et al., 2012 
34 4-MeC6H4CH2NHEt, cation 0.640 2.66 1.44 0.00 1.4013 1.2994 0.0000 1.0 0.0 -6.77 -6.74 Zhang et al., 2012 
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35 4-MeC6H4CH2NHMe, cation 0.650 2.58 1.42 0.00 1.2604 1.2835 0.0000 1.0 0.0 -7.51 -6.92 Zhang et al., 2012 
36 4-MeC6H4CH2NHPr, cation 0.630 2.63 1.37 0.00 1.5422 1.3290 0.0000 1.0 0.0 -6.77 -6.49 Zhang et al., 2012 
37 4-nitrophenol 1.070 1.72 0.82 0.26 0.9493 0.0000 0.0000 1.0 0.0 -5.33 -5.42 Baba et al., 2015 
38 4-propoxyphenol 0.840 1.17 0.57 0.52 1.2565 0.0000 0.0000 1.0 0.0 -5.18 -5.12 Baba et al., 2015 
39 5,5-diethylbarbituric acid 1.030 1.14 0.47 1.18 1.3739 0.0000 0.0000 1.0 0.0 -7.29 -6.43 Zhang et al., 2012 
40 5-ethyl-5-(3-methylbutyl)barbital 1.030 1.11 0.47 1.23 1.7966 0.0000 0.0000 1.0 0.0 -5.98 -5.77 Zhang et al., 2012 
41 5-ethyl-5-butylbarbituric acid 1.030 1.14 0.47 1.18 1.6557 0.0000 0.0000 1.0 0.0 -7.05 -5.92 Zhang et al., 2012 
42 5-ethyl-5-phenylbarbital 1.630 1.80 0.73 1.15 1.6999 0.0000 0.0000 1.0 0.0 -6.68 -6.17 Zhang et al., 2012 
43 5-fluorouracil 0.720 0.84 0.57 1.02 0.7693 0.0000 0.0000 1.0 0.0 -6.82 -7.02 Zhang et al., 2012 
44 8-methoxypsoralen 1.611 1.70 0.00 0.80 1.4504 0.0000 0.0000 1.0 0.0 -5.12 -5.47 Zhang et al., 2012 
45 acetic acid 0.265 0.64 0.62 0.44 0.4648 0.0000 0.0000 1.0 0.0 -6.08 -6.12 Baba et al., 2015 
46 acetylsalicylic acid 0.781 1.69 0.71 0.67 1.2879 0.0000 0.0000 0.0 1.0 -5.50 -5.79 Baba et al., 2015 
47 aldosterone 2.010 3.47 0.40 1.90 2.6890 0.0000 0.0000 1.0 0.0 -7.45 -7.06 Zhang et al., 2012 
48 alprenolol, neutral, Fn = 0.02, log Kp(t) = -6.90 1.250 1.09 0.15 1.44 2.16 0.0000 0.0000 1.0 0.0 -5.30 -5.48 
Zhang et al., 
2012 
49 alprenolol, cation, Fi = 0.98, log Kp(t) =-6.90 1.100 4.46 1.78 0.00 2.1802 2.2574 0.0000 1.0 0.0 -7.59 -7.90 
Zhang et al., 
2012 
50 aminopyrine 1.680 1.74 0.00 1.60 1.8662 0.0000 0.0000 0.0 1.0 -6.55 -6.68 Baba et al., 2015 
51 amylobarbital 1.030 1.10 0.59 1.22 1.7966 0.0000 0.0000 0.0 1.0 -6.00 -5.78 Baba et al., 2015 
52 aniline 0.955 0.96 0.26 0.41 0.8162 0.0000 0.0000 1.0 0.0 -4.94 -5.39 Baba et al., 2015 
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53 anisole 0.708 0.75 0.00 0.29 0.9160 0.0000 0.0000 1.0 0.0 -4.41 -4.74 Baba et al., 2015 
54 atenolol 1.450 1.90 0.62 2.03 2.1763 0.0000 0.0000 1.0 0.0 -7.35 -7.50 Baba et al., 2015 
55 barbital 1.030 1.00 0.58 1.12 1.3739 0.0000 0.0000 0.0 1.0 -7.31 -6.24 Baba et al., 2015 
56 benzaldehyde 0.820 1.00 0.00 0.39 0.8730 0.0000 0.0000 1.0 0.0 -4.51 -5.20 Baba et al., 2015 
57 benzene 0.610 0.52 0.00 0.14 0.7164 0.0000 0.0000 1.0 0.0 -4.27 -4.61 Zhang et al., 2012 
58 benzenetriol 1.180 1.37 1.40 0.68 0.8925 0.0000 0.0000 1.0 0.0 -6.98 -6.51 Baba et al., 2015 
59 benzoic acid 0.730 0.90 0.59 0.40 0.9317 0.0000 0.0000 1.0 0.0 -5.68 -5.27 Baba et al., 2015 
60 benzyl alcohol 0.803 0.87 0.39 0.56 0.9160 0.0000 0.0000 1.0 0.0 -5.30 -5.59 Zhang et al., 2012 
61 benzyl nicotinate 1.262 1.60 0.00 0.80 1.6393 0.0000 0.0000 1.0 0.0 -4.87 -5.12 Zhang et al., 2012 
62 betamethasone 2.040 3.51 0.71 1.92 2.9132 0.0000 0.0000 1.0 0.0 -7.15 -6.83 Baba et al., 2015 
63 betamethasone-17-valerate 1.970 3.10 0.56 2.40 3.6334 0.0000 0.0000 1.0 0.0 -6.50 -6.42 Baba et al., 2015 
64 bromoacetic acid Fi = 0.70, log Kp(t) = -6.52 0.706 3.66 0.00 0.82 0.6183 0.0000 0.1469 1.0 0.0 -8.01 -7.96 
Baba et al., 
2015 
65 bromoacetic acid Fn = 0.30 log Kp(t) = -6.52 0.556 1.06 0.77 0.38 0.6398 0.0000 0.0000 1.0 0.0 -6.01 -5.92 
Baba et al., 
2015 
66 bromochloroacetic acid Fi =0.90, log Kp(t) =-6.46 0.790 3.18 0.10 2.48 0.7407 0.0000 1.9889 1.0 0.0 -6.82 -6.95 
Baba et al., 
2015 
67 bromochloroacetic acid Fn = 0.10, log Kp(t) = -6.46 0.640 1.24 0.92 0.28 0.7622 0.0000 0.0000 1.0 0.0 -5.67 -5.61 
Baba et al., 
2015 
68 bromochloroacetonitrile 0.597 1.10 0.22 0.21 0.7016 0.0000 0.0000 1.0 0.0 -4.35 -5.23 Baba et al., 2015 
69 bromodichloromethane 0.593 0.69 0.10 0.04 0.6693 0.0000 0.0000 1.0 0.0 -4.41 -4.59 Baba et al., 2015 
70 butan-1-ol 0.224 0.42 0.37 0.48 0.7309 0.0000 0.0000 1.0 0.0 -5.70 -5.53 Zhang et al., 2012 
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71 butan-2,3-diol 0.341 0.93 0.61 0.88 0.7896 0.0000 0.0000 1.0 0.0 -7.38 -6.77 Zhang et al., 2012 
72 butan-2-one 0.166 0.70 0.00 0.51 0.6879 0.0000 0.0000 1.0 0.0 -5.42 -5.73 Zhang et al., 2012 
73 butanoic acid 0.210 0.64 0.61 0.45 0.7466 0.0000 0.0000 0.0 0.0 -6.41 -5.64 Baba et al., 2015 
74 butobarbital 1.030 1.14 0.47 1.18 1.6557 0.0000 0.0000 0.0 1.0 -7.07 -5.92 Baba et al., 2015 
75 butoxyethanol 0.201 0.53 0.26 0.83 1.0714 0.0000 0.0000 1.0 0.0 -6.00 -5.80 Baba et al., 2015 
76 butyl nicotinate 0.658 1.07 0.00 0.73 1.4542 0.0000 0.0000 1.0 0.0 -4.86 -5.04 Zhang et al., 2012 
77 butyl p-aminobenzoate 1.010 1.35 0.30 0.68 1.5951 0.0000 0.0000 1.0 0.0 -4.41 -4.89 Baba et al., 2015 
78 butyl paraben  0.900 1.47 0.74 0.43 1.5540 0.0000 0.0000 1.0 0.0 -4.34 -4.59 Akomeah et al., 2007 
79 C6H5(CH2)2COOH  0.750 1.18 0.60 0.60 1.2135 0.0000 0.0000 1.0 0.0 -4.93 -5.42 
Zhang et al., 
2012 
80 C6H5(CH2)2COOH, anion 0.900 3.43 0.03 3.02 1.1920 0.0000 2.1879 1.0 0.0 -6.78 -7.07 
Zhang et al., 
2012 
81 C6H5(CH2)3COOH 0.760 1.29 0.61 0.57 1.3544 0.0000 0.0000 1.0 0.0 -4.85 -5.16 
Zhang et al., 
2012 
82 C6H5(CH2)3COOH, anion 0.910 3.59 0.04 3.01 1.3329 0.0000 2.2184 1.0 0.0 -6.70 -6.82 
Zhang et al., 
2012 
83 C6H5(CH2)4COOH 0.770 1.24 0.57 0.60 1.4933 0.0000 0.0000 1.0 0.0 -4.30 -4.94 
Zhang et al., 
2012 
84 C6H5(CH2)4COOH, anion 0.920 3.63 0.04 3.10 1.4718 0.0000 2.2794 1.0 0.0 -6.15 -6.66 
Zhang et al., 
2012 
85 C6H5(CH2)7COOH 0.790 1.27 0.57 0.62 1.7771 0.0000 0.0000 1.0 0.0 -3.86 -4.49 
Zhang et al., 
2012 
86 C6H5(CH2)7COOH, anion 0.940 3.87 0.07 3.26 1.8965 0.0000 2.4256 1.0 0.0 -5.71 -6.07 
Zhang et al., 
2012 
87 C6H5COOH 0.730 0.90 0.59 0.40 0.9317 0.0000 0.0000 1.0 0.0 -4.91 -5.27 
Zhang et al., 
2012 
88 C6H5COOH, anion 0.880 3.05 0.02 2.75 0.9102 0.0000 2.1385 1.0 0.0 -6.76 -6.81 




89 caffeine 1.500 1.82 0.08 1.25 1.3632 0.0000 0.0000 1.0 0.0 -6.85 -6.83 Akomeah et al., 2007 
90 catechol 0.970 1.10 0.88 0.47 0.8338 0.0000 0.0000 1.0 0.0 -5.87 -5.80 Baba et al., 2015 
91 chloral hydrate 0.814 0.96 0.59 0.56 0.8750 0.0000 0.0000 1.0 0.0 -5.97 -5.78 Baba et al., 2015 
92 chloroacetic acid, Fi = 0.90, log Kp(t) = -6.62 0.577 2.94 0.00 1.10 0.5657 0.0000 0.3680 1.0 0.0 -7.78 -7.77 
Baba et al., 
2015 
93 chloroacetic acid, Fn = 0.1, log Kp(t) = -6.62 0.427 1.03 0.79 0.35 0.5872 0.0000 0.0000 1.0 0.0 -5.97 -5.95 
Baba et al., 
2015 
94 chloroacetonitrile 0.372 0.89 0.38 0.26 0.5266 0.0000 0.0000 1.0 0.0 -4.56 -5.63 Baba et al., 2015 
95 chlorodibromomethane 0.775 0.68 0.12 0.10 0.7219 0.0000 0.0000 1.0 0.0 -4.37 -4.62 Baba et al., 2015 
96 chlorpheniramine 1.465 1.41 0.00 1.33 2.2098 0.0000 0.0000 0.0 1.0 -5.93 -5.24 Baba et al., 2015 
97 codeine 2.220 2.15 0.15 1.80 2.2057 0.0000 0.0000 1.0 0.0 -6.57 -6.78 Zhang et al., 2012 
98 codeine cation 2.070 5.83 2.68 0.00 2.2272 2.9847 0.0000 0.0 0.0 -10.01 -9.90 Roy and Flynn, 1989 
99 cortexolone 1.910 3.45 0.36 1.60 2.7389 0.0000 0.0000 1.0 0.0 -7.20 -6.23 Baba et al., 2015 
100 cortexone 1.740 3.50 0.14 1.31 2.6802 0.0000 0.0000 1.0 0.0 -6.42 -5.61 Baba et al., 2015 
101 corticosterone 1.860 3.43 0.40 1.63 2.7389 0.0000 0.0000 1.0 0.0 -6.84 -6.31 Zhang et al., 2012 
102 cortisone 1.960 3.50 0.36 1.87 2.7546 0.0000 0.0000 1.0 0.0 -7.38 -6.88 Baba et al., 2015 
103 coumarin 1.230 1.68 0.00 0.52 1.0619 0.0000 0.0000 0.0 1.0 -5.60 -5.53 Baba et al., 2015 
104 cyclobarbitone 1.440 1.35 0.49 1.45 1.7859 0.0000 0.0000 0.0 1.0 -6.65 -6.42 Baba et al., 2015 
105 cytarabine 2.090 2.25 0.87 2.12 1.6234 0.0000 0.0000 1.0 0.0 -8.66 -8.92 Baba et al., 2015 
106 decan-1-ol 0.191 0.42 0.37 0.48 1.5763 0.0000 0.0000 1.0 0.0 -4.15 -4.01 Zhang et al., 2012 
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107 dexamethasone 2.040 3.51 0.71 1.92 2.9132 0.0000 0.0000 0.0 0.0 -7.27 -6.83 Zhang et al., 2012 
108 diazinon 1.310 1.55 0.00 1.40 2.3056 0.0000 0.0000 1.0 0.0 -5.62 -5.34 Baba et al., 2015 
109 dibromoacetic acid, Fi = 0.85, log Kp(t) = -6.25 0.948 3.34 0.11 2.53 0.7955 0.0000 2.0502 1.0 0.0 -6.76 -6.90 
Baba et al., 
2015 
110 dibromoacetic acid, Fn = 0.15, log Kp(t) =-6.25 0.798 1.24 0.92 0.31 0.8147 0.0000 0.0000 1.0 0.0 -5.57 -5.57 
Baba et al., 
2015 
111 dibromoacetonitrile 0.766 1.24 0.25 0.26 0.7542 0.0000 0.0000 1.0 0.0 -4.33 -5.33 Baba et al., 2015 
112 dichloroacetic acid, Fi = 0.80, log Kp(t) = -6.39 0.632 2.53 0.00 2.18 0.6881 0.0000 1.4260 1.0 0.0 -7.21 -7.30 
Baba et al., 
2015 
113 dichloroacetic acid, Fn = 0.20, log Kp(t) = -6.39 0.482 1.20 0.92 0.26 0.7096 0.0000 0.0000 1.0 0.0 -5.75 -5.65 
Baba et al., 
2015 
114 dichloroacetonitrile 0.428 0.96 0.20 0.17 0.6490 0.0000 0.0000 1.0 0.0 -4.38 -5.16 Baba et al., 2015 
115 diclofenac 1.810 1.85 0.55 0.77 2.0250 0.0000 0.0000 1.0 0.0 -5.30 -4.61 Zhang et al., 2012 
116 diclofenac, anion 1.960 5.31 0.03 3.35 2.0035 0.0000 2.6243 1.0 0.0 -7.00 -6.32 Zhang et al., 2012 
117 diethylcarbamazine 0.645 1.30 0.00 1.55 1.7241 0.0000 0.0000 1.0 0.0 -6.15 -6.69 Zhang et al., 2012 
118 diethylether 0.041 0.25 0.00 0.45 0.7309 0.0000 0.0000 1.0 0.0 -5.37 -5.25 Zhang et al., 2012 
119 digitoxin 3.460 5.63 1.33 4.35 5.6938 0.0000 0.0000 1.0 0.0 -8.15 -9.03 Zhang et al., 2012 
120 dihydrocodeine 2.060 2.32 0.26 1.74 2.2487 0.0000 0.0000 1.0 0.0 -6.00 -6.72 Zhang et al., 2012 
121 dihydromorphine 2.080 1.35 0.42 2.04 2.1078 0.0000 0.0000 1.0 0.0 -7.58 -7.16 Zhang et al., 2012 
122 dimethylethylamine 0.094 0.18 0.00 0.64 0.7720 0.0000 0.0000 1.0 0.0 -5.80 -5.59 Baba et al., 2015 
123 ephedrine 0.916 0.74 0.21 1.21 1.4385 0.0000 0.0000 0.0 1.0 -5.50 -6.07 Baba et al., 2015 
124 estradiol 1.800 1.77 0.86 1.10 2.1988 0.0000 0.0000 1.0 0.0 -5.61 -5.16 Zhang et al., 2012 
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125 estrone 1.730 2.05 0.50 1.08 2.1558 0.0000 0.0000 1.0 0.0 -5.52 -5.24 Baba et al., 2015 
126 ethacrynic acid anion 1.500 4.91 0.07 3.65 2.0318 0.0000 2.5114 1.0 0.0 -7.38 -7.12 Baba et al., 2015 
127 ethanol 0.246 0.42 0.37 0.48 0.4491 0.0000 0.0000 1.0 0.0 -6.08 -6.03 Zhang et al., 2012 
128 ethyl nicotinate 0.667 1.10 0.00 0.73 1.1724 0.0000 0.0000 1.0 0.0 -5.28 -5.57 Zhang et al., 2012 
129 ethyl p-aminobenzoate 1.030 1.31 0.31 0.69 1.3133 0.0000 0.0000 1.0 0.0 -5.06 -5.40 Baba et al., 2015 
130 ethylbenzene 0.613 0.51 0.00 0.15 0.9982 0.0000 0.0000 1.0 0.0 -3.00 -4.12 Zhang et al., 2012 
131 ethylene glycol mono isopropyl ether 0.196 0.48 0.21 0.91 0.9305 0.0000 0.0000 1.0 0.0 -6.71 -6.20 Baba et al., 2015 
132 ethylene glycol mono methyl ether acetate 0.166 0.79 0.00 0.81 0.9462 0.0000 0.0000 1.0 0.0 -6.10 -6.05 Baba et al., 2015 
133 ethylene glycol mono propyl ether 0.212 0.50 0.30 0.83 0.9305 0.0000 0.0000 1.0 0.0 -6.34 -6.05 Baba et al., 2015 
134 etodolac 1.803 2.17 1.05 1.15 2.2390 0.0000 0.0000 0.0 1.0 -5.48 -5.51 Baba et al., 2015 
135 famotidine 2.690 2.14 1.20 2.50 2.2617 0.0000 0.0000 0.0 1.0 -8.15 -8.66 Baba et al., 2015 
136 fentanyl  1.830 1.75 0.00 1.81 2.8399 0.0000 0.0000 1.0 0.0 -5.81 -5.42 Baba et al., 2015 
137 fentanyl cation 1.680 5.67 2.22 0.00 2.8615 2.8615 0.0000 0.0 0.0 -8.21 -8.38 Roy and Flynn, 1990 
138 fluocinonide 1.950 2.48 0.31 2.51 3.4603 0.0000 0.0000 1.0 0.0 -6.33 -6.54 Zhang et al., 2012 
139 flurbiprofen, neutral, Fn = 0.01, log Kp(t) = -6.20 1.440 1.45 0.62 0.76 1.84 0.0000 0.0000 1.0 0.0 -4.72 -4.75 
Zhang et al., 
2012 
140 flurbiprofen, anion, Fi = 0.99, log Kp(t)  = -6.20 1.590 4.56 0.07 3.36 1.8174 0.0000 2.5383 1.0 0.0 -6.36 -6.51 
Zhang et al., 
2012 
141 flurbiprofen glucoside 2.321 3.80 0.85 1.80 2.8693 0.0000 0.0000 1.0 0.0 -6.28 -6.80 Swart et al., 2005 
142 flurbiprofen mannoside 2.321 3.73 0.85 1.95 2.8693 0.0000 0.0000 1.0 0.0 -6.74 -7.13 Swart et al., 2005 
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143 glycerol trinitrate 0.586 2.11 0.00 0.35 1.2300 0.0000 0.0000 1.0 0.0 -5.21 -5.16 Zhang et al., 2012 
144 griseofulvin 1.750 2.64 0.00 1.44 2.3947 0.0000 0.0000 0.0 1.0 -6.44 -5.87 Baba et al., 2015 
145 heptan-1-ol   0.211 0.42 0.37 0.48 1.1536 0.0000 0.0000 0.0 0.0 -4.57 -4.77 Zhang et al., 2012 
146 heptanoic acid 0.149 0.64 0.62 0.44 1.1693 0.0000 0.0000 0.0 0.0 -5.26 -4.87 Baba et al., 2015 
147 hexan-1-ol   0.210 0.42 0.37 0.48 1.0127 0.0000 0.0000 1.0 0.0 -4.92 -5.02 Zhang et al., 2012 
148 hexanoic acid 0.174 0.63 0.62 0.44 1.0284 0.0000 0.0000 0.0 0.0 -5.48 -5.11 Baba et al., 2015 
149 hexyl nicotinate 0.628 1.07 0.00 0.73 1.7360 0.0000 0.0000 1.0 0.0 -4.83 -4.54 Zhang et al., 2012 
150 hydrocodone 2.030 1.81 0.00 1.85 2.2057 0.0000 0.0000 1.0 0.0 -6.26 -6.67 Zhang et al., 2012 
151 hydrocortisone 2.030 3.49 0.71 1.90 2.7976 0.0000 0.0000 1.0 0.0 -7.22 -6.98 Zhang et al., 2012 
152 hydrocortisone hemipimelate 2.020 3.58 1.06 2.61 3.8740 0.0000 0.0000 0.0 0.0 -6.24 -6.94 Zhang et al., 2012 
153 hydrocortisone hemisuccinate 2.100 3.15 1.06 2.61 3.4513 0.0000 0.0000 0.0 0.0 -6.69 -7.43 Zhang et al., 2012 
154 hydrocortisone hexanoate 1.810 3.02 0.46 2.16 3.6587 0.0000 0.0000 0.0 0.0 -5.30 -5.73 Zhang et al., 2012 
155 hydrocortisone hydroxyhexanoate 2.020 3.49 0.83 2.64 3.7174 0.0000 0.0000 0.0 0.0 -6.60 -7.17 Zhang et al., 2012 
156 hydrocortisone methylpimelate 1.930 3.49 0.46 2.61 4.0149 0.0000 0.0000 0.0 0.0 -5.82 -6.45 Zhang et al., 2012 
157 hydrocortisone methylsuccinate 1.990 3.11 0.46 2.61 3.5922 0.0000 0.0000 0.0 0.0 -7.23 -6.97 Zhang et al., 2012 
158 hydrocortisone N,N-dimethylsuccinate 2.210 3.77 0.46 2.86 3.7742 0.0000 0.0000 0.0 0.0 -7.73 -7.62 Zhang et al., 2012 
159 hydrocortisone octanoate  1.770 3.05 0.46 2.16 3.9405 0.0000 0.0000 0.0 0.0 -4.76 -5.24 Zhang et al., 2012 
160 hydrocortisone pimelamate 2.210 4.15 0.96 2.78 3.9151 0.0000 0.0000 0.0 0.0 -6.61 -7.57 Zhang et al., 2012 
161 hydrocortisone propionate   1.870 2.90 0.46 2.16 3.2360 0.0000 0.0000 0.0 0.0 -6.02 -6.41 Zhang et al., 2012 
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162 hydrocortisone succinamate   2.310 3.32 1.01 2.84 3.4924 0.0000 0.0000 0.0 0.0 -8.14 -7.98 Zhang et al., 2012 
163 hydromorphone 2.040 1.60 0.16 1.95 2.0648 0.0000 0.0000 1.0 0.0 -7.83 -7.09 Zhang et al., 2012 
164 hydroquinone   1.063 1.27 1.06 0.57 0.8338 0.0000 0.0000 1.0 0.0 -6.31 -6.19 Baba et al., 2015 
165 hydroxypregnenolone   1.550 3.35 0.57 1.35 2.7232 0.0000 0.0000 1.0 0.0 -6.30 -5.71 Baba et al., 2015 
166 hydroxyprogesterone 1.640 3.35 0.25 1.31 2.6802 0.0000 0.0000 1.0 0.0 -6.30 -5.57 Baba et al., 2015 
167 ibuprofen, neutral, Fn = 0.03, log Kp(t) = -5.83 0.730 0.70 0.57 0.79 1.7771 0.0000 0.0000 1.0 0.0 -4.58 -4.57 
Zhang et al., 
2012 
168 ibuprofen, anion , Fi = 0.97, log Kp(t)  = -5.83 0.880 3.50 0.08 3.31 1.7556 0.0000 2.4188 1.0 0.0 -6.15 -6.25 
Zhang et al., 
2012 
169 ibuprofen glucoside 1.826 3.11 0.85 2.00 2.8075 0.0000 0.0000 1.0 0.0 -6.94 -7.05 Swart et al., 2005 
170 ibuprofen mannoside 1.826 2.79 0.85 2.00 2.8075 0.0000 0.0000 1.0 0.0 -6.55 -6.86 Swart et al., 2005 
171 indomethacin 2.240 1.47 0.58 1.43 2.5299 0.0000 0.0000 1.0 0.0 -5.39 -5.03 Zhang et al., 2012 
172 indomethacin anion 2.390 5.62 0.10 4.38 2.5084 0.0000 2.9899 1.0 0.0 -7.22 -7.17 Zhang et al., 2012 
173 isoquinoline 1.211 1.00 0.00 0.54 1.0443 0.0000 0.0000 0.0 1.0 -5.11 -5.20 Zhang et al., 2012 
174 iso-thymol 0.824 0.81 0.56 0.43 1.3387 0.0000 0.0000 1.0 0.0 -4.84 -4.53 Baba et al., 2015 
175 ketoprofen, neutral, Fn = 0.50, logKp(t) = -5.51 1.650 2.26 0.55 0.89 1.9779 0.0000 0.0000 1.0 0.0 -5.22 -5.26 
Zhang et al., 
2012 
176 ketoprofen, anion, Fi = 0.50, logKp(t)  = -5.51 1.800 5.49 0.01 3.39 1.9564 0.0000 2.4851 1.0 0.0 -6.84 -6.97 
Zhang et al., 
2012 
177 ketoprofen glucoside 2.628 4.22 0.85 2.20 3.0082 0.0000 0.0000 1.0 0.0 -7.73 -7.74 Swart et al., 2005 
178 ketoprofen mannoside 2.628 4.07 0.85 2.20 3.0082 0.0000 0.0000 1.0 0.0 -7.59 -7.65 Swart et al., 2005 
179 ketorolac 1.600 2.03 0.65 1.05 1.8712 0.0000 0.0000 1.0 0.0 -5.60 -5.74 Baba et al., 2015 
180 levosimendan 2.100 1.76 0.70 1.60 2.0915 0.0000 0.0000 1.0 0.0 -6.00 -6.46 Baba et al., 2015 
19 
 
181 lidocaine   1.110 1.51 0.07 1.24 2.0589 0.0000 0.0000 1.0 0.0 -5.51 -5.42 Baba et al., 2015 
182 lidocaine cation 0.960 4.18 2.12 0.00 2.0804 1.7490 0.0000 1.0 0.0 -7.42 -7.29 Baba et al., 2015 
183 linolenic acid anion 0.698 3.59 0.14 3.90 2.5687 0.0000 2.6821 1.0 0.0 -5.99 -5.67 Baba et al., 2015 
184 mannitol 0.836 2.33 0.87 1.77 1.3062 0.0000 0.0000 1.0 0.0 -8.42 -8.86 Zhang et al., 2012 
185 m-cresol 0.822 0.88 0.57 0.34 0.9160 0.0000 0.0000 1.0 0.0 -4.89 -5.12 Zhang et al., 2012 
186 meperidine cation 0.840 4.25 1.93 0.00 2.0716 1.8235 0.0000 1.0 0.0 -7.43 -7.41 Baba et al., 2015 
187 methanol 0.278 0.44 0.43 0.47 0.3082 0.0000 0.0000 1.0 0.0 -6.38 -6.29 Zhang et al., 2012 
188 methyl 4-hydroxyphenylacetate 0.908 1.36 0.59 0.70 1.2722 0.0000 0.0000 0.0 0.0 -5.26 -5.64 Baba et al., 2015 
189 methyl nicotinate 0.710 1.13 0.00 0.71 1.0315 0.0000 0.0000 1.0 0.0 -5.77 -5.78 Zhang et al., 2012 
190 methyl p-aminobenzoate 1.030 1.25 0.30 0.72 1.1724 0.0000 0.0000 1.0 0.0 -4.99 -5.68 Baba et al., 2015 
191 methyl paraben  0.930 1.46 0.71 0.46 1.1313 0.0000 0.0000 1.0 0.0 -5.03 -5.41 Akomeah et al., 2007 
192 methyl salicylate 0.850 0.84 0.02 0.47 1.1313 0.0000 0.0000 1.0 0.0 -4.80 -4.83 Baba et al., 2015 
193 methylphenylether 0.708 0.75 0.00 0.29 0.9160 0.0000 0.0000 1.0 0.0 -4.68 -4.74 Zhang et al., 2012 
194 methyltriglycol nicotinate 0.730 1.42 0.00 1.79 2.0530 0.0000 0.0000 1.0 0.0 -6.83 -6.74 Zhang et al., 2012 
195 morphine 2.230 1.30 0.39 2.01 2.0648 0.0000 0.0000 1.0 0.0 -7.24 -7.11 Zhang et al., 2012 
196 naproxen 1.510 2.02 0.60 0.67 1.7821 0.0000 0.0000 1.0 0.0 -4.97 -4.97 Zhang et al., 2012 
197 naproxen, anion 1.660 5.07 0.02 3.11 1.7606 0.0000 2.4260 1.0 0.0 -6.53 -6.56 Zhang et al., 2012 
198 naproxen glucoside 2.818 3.81 0.85 2.10 2.8124 0.0000 0.0000 1.0 0.0 -7.89 -7.57 Swart et al., 2005 
199 naproxen mannoside 2.818 3.73 0.85 2.10 2.8124 0.0000 0.0000 1.0 0.0 -7.70 -7.52 Swart et al., 2005 
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200 nicorandil 1.100 2.60 0.39 1.28 1.4464 0.0000 0.0000 0.0 1.0 -7.30 -7.39 Baba et al., 2015 
201 nicotine 0.865 0.88 0.00 1.09 1.3710 0.0000 0.0000 1.0 0.0 -5.34 -5.92 Baba et al., 2015 
202 nimesulide 2.109 2.70 0.31 1.09 2.0787 0.0000 0.0000 0.0 1.0 -6.35 -5.68 Baba et al., 2015 
203 nizatidine 1.910 2.92 0.64 2.41 2.4622 0.0000 0.0000 0.0 1.0 -7.78 -8.47 Baba et al., 2015 
204 nonan-1-ol 0.193 0.42 0.37 0.48 1.4354 0.0000 0.0000 1.0 0.0 -4.30 -4.27 Zhang et al., 2012 
205 o-cresol 0.840 0.86 0.52 0.30 0.9160 0.0000 0.0000 1.0 0.0 -4.88 -4.99 Zhang et al., 2012 
206 octan-1-ol 0.199 0.42 0.37 0.48 1.2945 0.0000 0.0000 1.0 0.0 -4.30 -4.52 Zhang et al., 2012 
207 octanoic acid 0.150 0.65 0.62 0.45 1.3102 0.0000 0.0000 0.0 0.0 -5.18 -4.65 Baba et al., 2015 
208 o-phenylenediamine 1.260 1.40 0.24 0.73 0.9160 0.0000 0.0000 1.0 0.0 -6.70 -6.21 Zhang et al., 2012 
209 o-tert-butylphenol 0.823 0.92 0.52 0.40 1.3387 0.0000 0.0000 1.0 0.0 -4.48 -4.51 Baba et al., 2015 
210 ouabain 4.010 6.20 0.90 3.46 4.1615 0.0000 0.0000 1.0 0.0 -9.66 -9.75 Zhang et al., 2012 
211 oxycodone 2.320 2.50 0.29 1.91 2.2644 0.0000 0.0000 1.0 0.0 -6.43 -7.18 Zhang et al., 2012 
212 oxymorphone 2.320 2.10 0.39 1.90 2.1235 0.0000 0.0000 1.0 0.0 -7.60 -7.21 Zhang et al., 2012 
213 p-cresol 0.820 0.87 0.57 0.31 0.9160 0.0000 0.0000 1.0 0.0 -4.83 -5.04 Zhang et al., 2012 
214 pentan-1-ol 0.219 0.42 0.37 0.48 0.8718 0.0000 0.0000 0.0 0.0 -5.30 -5.28 Zhang et al., 2012 
215 pentanoic acid 0.205 0.63 0.62 0.45 0.8875 0.0000 0.0000 0.0 0.0 -6.11 -5.39 Baba et al., 2015 
216 phenobarbital 1.630 1.72 0.71 1.18 1.6999 0.0000 0.0000 0.0 1.0 -6.70 -6.19 Baba et al., 2015 
217 phenol 0.805 0.89 0.60 0.30 0.7751 0.0000 0.0000 1.0 0.0 -5.27 -5.29 Zhang et al., 2012 
218 phloroglucinol 1.360 1.39 1.40 0.73 0.8925 0.0000 0.0000 1.0 0.0 -5.87 -6.62 Baba et al., 2015 
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219 piroxicam, anion 2.710 6.81 0.00 3.78 2.2285 0.0000 2.7356 1.0 0.0 -7.50 -7.48 Zhang et al., 2012 
220 piroxicam, neutral 2.560 2.90 0.17 1.49 2.2500 0.0000 0.0000 1.0 0.0 -6.02 -6.36 Zhang et al., 2012 
221 p-phenylenediamine 1.300 1.66 0.44 0.83 0.9160 0.0000 0.0000 1.0 0.0 -6.98 -6.67 Zhang et al., 2012 
222 prednisolone 2.210 3.10 0.71 1.92 2.7546 0.0000 0.0000 1.0 0.0 -7.91 -6.85 Baba et al., 2015 
223 pregnenolone 1.360 3.29 0.32 1.18 2.6645 0.0000 0.0000 1.0 0.0 -5.90 -5.31 Baba et al., 2015 
224 progesterone 1.450 3.29 0.00 1.14 2.6215 0.0000 0.0000 1.0 0.0 -4.90 -5.17 Zhang et al., 2012 
225 propan-1-ol 0.236 0.42 0.37 0.48 0.5900 0.0000 0.0000 1.0 0.0 -5.93 -5.78 Zhang et al., 2012 
226 propranolol (Fn larger than 0.85) 1.840 1.43 0.44 1.31 2.1480 0.0000 0.0000 1.0 0.0 -6.05 -5.41 
Baba et al., 
2015 
227 propranolol, cation (Fi larger than 0.995) 1.690 4.31 2.07 0.00 2.1695 2.4319 0.0000 1.0 0.0 -7.70 -8.11 
Zhang et al., 
2012 
228 propylparaben 0.900 1.45 0.74 0.43 1.4131 0.0000 0.0000 1.0 0.0 -5.41 -4.83 Baba et al., 2015 
229 pyrogallol 1.165 1.26 1.35 0.64 0.8925 0.0000 0.0000 1.0 0.0 -6.17 -6.33 Baba et al., 2015 
230 ranitidine 1.600 1.63 0.25 2.33 2.3985 0.0000 0.0000 0.0 1.0 -7.41 -7.52 Baba et al., 2015 
231 resorcinol 0.980 1.11 1.09 0.52 0.8338 0.0000 0.0000 1.0 0.0 -6.70 -6.00 Zhang et al., 2012 
232 salicylic acid 0.900 0.85 0.73 0.37 0.9904 0.0000 0.0000 1.0 0.0 -5.07 -5.08 Zhang et al., 2012 
233 salicylic acid, anion 1.050 3.19 0.08 2.74 0.9689 0.0000 2.2641 1.0 0.0 -7.04 -6.45 Zhang et al., 2012 
234 scopolamine 1.686 1.32 0.09 2.17 2.2321 0.0000 0.0000 0.0 1.0 -7.58 -7.18 Baba et al., 2015 
235 sufentanil  1.800 2.28 0.00 1.91 3.1051 0.0000 0.0000 1.0 0.0 -5.53 -5.51 Baba et al., 2015 
236 sufentanil cation 1.650 6.16 3.02 0.00 3.1266 2.5848 0.0000 1.0 0.0 -8.11 -8.06 Baba et al., 2015 
237 testosterone 1.540 2.56 0.32 1.17 2.3827 0.0000 0.0000 1.0 0.0 -5.54 -5.33 Zhang et al., 2012 
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238 theophylline 1.500 1.60 0.54 1.34 1.2223 0.0000 0.0000 1.0 0.0 -6.92 -7.33 Baba et al., 2015 
239 thymol 0.822 0.80 0.43 0.44 1.3387 0.0000 0.0000 1.0 0.0 -4.35 -4.51 Zhang et al., 2012 
240 toluene 0.601 0.52 0.00 0.14 0.8573 0.0000 0.0000 0.0 0.0 -3.64 -4.36 Zhang et al., 2012 
241 tribromomethane 0.974 0.68 0.15 0.06 0.7745 0.0000 0.0000 1.0 0.0 -4.34 -4.41 Baba et al., 2015 
242 trichloroacetic acid, Fi = 0.90, log Kp(t) = -6.39 0.674 3.08 0.14 2.48 0.8105 0.0000 1.9882 1.0 0.0 -6.75 -6.80 
Baba et al., 
2015 
243 trichloroacetic acid, Fn= 0.10, log Kp(t) = -6.39 0.524 1.21 1.01 0.26 0.8320 0.0000 0.0000 1.0 0.0 -5.60 -5.46 
Baba et al., 
2015 
244 trichloromethane 0.425 0.49 0.15 0.02 0.6167 0.0000 0.0000 1.0 0.0 -4.46 -4.56 Baba et al., 2015 
245 triglycol nicotinate 0.950 1.58 0.37 1.78 1.9121 0.0000 0.0000 1.0 0.0 -8.08 -7.16 Zhang et al., 2012 
246 urea 0.501 1.49 0.83 0.84 0.4646 0.0000 0.0000 1.0 0.0 -7.93 -7.64 Zhang et al., 2012 
247 water 0.000 0.45 0.82 0.35 0.1673 0.0000 0.0000 1.0 0.0 -6.28 -6.43 Zhang et al., 2012 
a Kp in units of cm/s; values of solute descriptors of neutral compounds taken from Abraham et al. (2009), Abraham et al. (2007), Abraham et al. (2008), Stephens et al. 
(2012) and Zhang et al. (2012) or obtained as described before (Abraham et al., 2015a; Abraham et al., 2015b; Clarke and Mallon, 2012); ionic descriptors obtained as 






We made a distinction between skin permeation through stratum corneum or through full 
thickness skin or through intermediate thickness skin, by the use of indicator variables. For 
permeation through the stratum corneum, the indicator variable is zero because this is our 
‘standard system’. In column ‘Inter’, Table 2, all values are zero except for permeation through 
intermediate thickness where the indicator value = 1. In column ‘Full’ all values are zero except 
for permeation through full thickness skin where the indicator value = 1.  
     Regression of the values of log Kp against the descriptors in Eq. 2 and the two indicator 
variables ‘Inter’ and ‘Full’ leads to Eq. 4.   
log Kp = - 5.182(0.126) + 0.185(0.085) E - 0.617(0.057) S - 0.373(0.095) A - 2.412 (0.091) B 
+ 1.763(0.081) V - 1.440(0.122) J+ + 2.461(0.113) J- - 0.121(0.099) Inter 
               - 0.299(0.139) Full 
N = 247   SD = 0.430   R2 = 0.869   F = 174.70   PRESS =  47.550   Q2 = 0.858 
PSD = 0.448                                                                                    (4) 
Here and elsewhere, N is the number of compounds or species studied, R2 is the squared 
correlation coefﬁcient, SD is the standard deviation, and F is the Fisher F-statistic. PRESS and 
Q2 are the leave-one-out statistics and PSD is the predicted standard deviation (Abraham et 
al., 2009). The SD values for the coefficients are in parentheses. The coefficient 0.121 for the 
indicator variable ’inter’ is very small, only just larger than the SD value, and exclusion of this 
term results in Eq. 5.   
log Kp = - 5.311(0.071) + 0.159(0.082) E - 0.617(0.057) S - 0.352(0.094) A - 2.401(0.091) B + 
1.782 (0.079) V - 1.448(0.123) J+ + 2.450(0.113) J- - 0.190(0.108) Full 
N = 247   SD = 0.430   R2 = 0.868   F = 195.92   PRESS = 47.317   Q2 = 0.858  PSD = 0.446
                                                                                       (5) 
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If both of the terms in the indicator variables are left out, Eq. 6 is obtained. 
log Kp = - 5.328(0.071) + 0.137(0.082) E - 0.604(0.057) S - 0.338(0.094) A - 2.428(0.090) B + 
1.797(0.079) V - 1.485(0.121) J+ + 2.471(0.113) J- 
N = 247   SD = 0.432   R2 = 0.866   F = 221.48   PRESS = 47.335   Q2 = 0.858   PSD = 0.445 
                                                                                                  (6) 
         From a comparison of Eqs. 4, 5 and 6, it can be seen that the inclusion of the ‘Inter’ 
variable makes no difference to the statistics of the LFER equation. The effect of the ‘Full’ 
indicator variable is very small, and we suggest that Eq. 6 be used in the prediction of further 
values of log Kp. What our analysis indicates is that differences in the thickness of skin used 
make very little difference to the actual experimental value of Kp.  
        Eq. 6 shows reasonably similar coefficients to our previous equation deduced from only 
118 compounds, but with better values of SD (0.432) and R2 (0.866). To prevent overfitting, 
the predicted R2 (Q2) was calculated by the leave-one-out statistics, which may indicate how 
well the model predicts new observations. Q2 of Eq. 6 is 0.858, very close to the R2 value of 
0.866. This indicates that Eq. 6 can provide valid predictions for new observations without 
overfitting. The predictive standard deviation (PSD) can also be obtained using the same 
statistics; this gives the predictive accuracy of regression models (Abraham et al., 2009). The 
PSD value of Eq. 6 is 0.445, which indicates that Eq. 6 is a good predicting model for log Kp, 
especially for the cases including ions and ionic species. In Figure 2, a plot of observed log Kp 
versus predicted log Kp is shown for all the compounds and species involved into the 
calculation of Eq. 6. The data points for cationic and anionic species are found to scatter 
randomly around the line of identity, implying that no systematic bias for ionic species exists 
through Eq. 6.  
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        In the construction of Eq. 6, we made an approximation of the ratio Kp(n)/Kp(i), which is 
deduced from our previous model (Zhang et al., 2012) and the known descriptors, to estimate 
the values of Kp(n) and Kp(i) of partially ionized compounds in Table 2. Now we use Eq. 6 to 
calculate the values of Kp(n)/Kp(i), as shown in Table 3. Table 3 reveals that neutral acids and 
bases permeate across the human skin very much faster than their ionic species, but the 
actual ratio depends on their structures. 
Table 3. Calculated values of Kp(n)/Kp(i) using Eq.6  
Acids Kp(n)/Kp(i)  Bases Kp(n)/Kp(i) 
C6H5COOH 35  4-MeC6H4CH2NHMe 40 
C6H5(CH2)2COOH 45  4-MeC6H4CH2NHEt 43 
C6H5(CH2)3COOH 45  4-MeC6H4CH2NHPr 44 
C6H5(CH2)4COOH 52  4-MeC6H4CH2NHBu 43 
C6H5(CH2)7COOH 38  4-MeC6H4CH2NH(CH2)4Me 41 
chloroacetic acid 66  4-MeC6H4CH2NH(CH2)5Me 65 
bromoacetic acid 108  4-MeC6H4CH2NH(CH2)6Me 58 
dichloroacetic acid 45  alprenolol 266 
dibromoacetic acid 22  propranolol 505 
bromochloroacetic acid 22  sufentanil 352 
trichloroacetic acid 21  lidocaine 75 
piroxicam 13  meperidine 121 
salicylic acid 24  fentanyl 900 
naproxen 39  codeine 1323 
indomethacin 137    
ibuprofen 48    
ketoprofen 52    
flurbiprofen 57    
diclofenac 51    
ethacrynic acid 71    
linolenic acid 229    
 
        We have shown that Eq. 6 can be used to predict skin permeation of a wide range of 
cationic and anionic species, but it can also be used to predict values for permanent ions. In 
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our previous paper (Zhang et al., 2012), we used our constructed equation to predict values 
of log Kp for skin permeation for the sodium and tetraethylammonium ions, and we can do 
the same through Eq. 6. Values are for Na+:  -8.12 (obs) (Zhang et al., 2012), -7.41 (calc) (Zhang 
et al., 2012) and -7.55 (this work), and for Et4N+:  -7.84 (obs) (Zhang et al., 2012), -6.48 (calc) 
(Zhang et al., 2012) and -6.38 (this work), so that it is possible to predict log Kp for permanent 
ions with no more than a set of simple descriptors (Abraham and Acree, 2016).  
        We illustrate the prediction of log Kp with the examples shown in Table 4, for species that 
have never been studied in terms of skin permeation. We can extend our predictions as 
follows. In Eq. 3, values of the fraction ionized and neutral, Fi and Fn, depend on the pKa of the 
solute and the pH of the donor solution. Eq. 3 can then be used in reverse, and a total value 
of log Kp can be calculated for any set of Fi and Fn values. Since these depend on the pH of the 
donor solution, this amounts to a calculation of log Kp as a function of pH. We illustrate this 
in Figure 3 for ketoprofen, an acid with a pKa of 4.30; experimental data for the neutral and 
ionized forms from Zhang et al. (2012). 
Table 4. Prediction of log Kp for some neutral and ionic species  
Species E S A B V J+ J- log Kp (pred) 
3,4-dimethoxybenzoic acid 0.95 1.65 0.57 0.75 1.3309 0.000 0.000 -5.82 
3,4-dimethoxybenzoic acid, anion 1.04 3.93 0.00 3.17 1.3094 0.000 2.190 -7.49 
bupivacaine 1.32 2.10 0.34 1.33 2.5139 0.000 0.000 -5.24 
bupivacaine, cation 1.17 4.67 2.92 0.00 2.5354 1.592 0.000 -6.78 
 
       Eq. 3 and Figure 3 can be used to explain why models that do not distinguish between 
neutral and ionic species, still yield reasonable statistical results. Because Kp(n) is very much 
larger than Kp(i), partial ionization results in only a small diminution in the observed Kp value. 
Thus for ketoprofen, at pH = 4.3, when it is 50% neutral, our calculated log Kp is -5.55 as 
compared to our calculated value at 100 % neutral of -5.26. Even at pH 4.67 when ketoprofen 
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is only 30% in the neutral form, our calculated log Kp is -5.76, only 0.50 log units less than for 
the 100 % neutral species. Unless a particular compound is largely in the ionized form, use of 
neutral descriptors and neglect of ionization will lead to calculated log Kp values that are not 
too far out-of-line.  
      We cannot compare the result shown in Figure 3 with any previous such results, because 
this appears to be the first time that log Kp values have been predicted as a function of pH in 
this way. Indeed, we cannot compare our equation for permeation of neutral molecules and 
ionic species, Eq. 6, with any previous equation that includes ionic species other than our own 
equation (Zhang et al., 2012). What we can say is that our statistics for Eq. 6 compare 
favorably with those reported for equations that deal only with neutral species. One of the 
most recent, and successful, models for skin permeation is that of Baba et al. (2015) who used 
an SVM-Gaussian method in which 2732 descriptors per compound were initially computed. 
Reduction to 11 descriptors yielded an equation for 169 compounds with R2 = 0.867 and a 
root mean square error, RMSE = 0.423 log units. This can be compared to Eq. 6 where we use 
only 7 descriptors from the beginning, and for 247 species find that R2 = 0.866 and RMSE = 
0.425 log units. 
 
CONCLUSION 
The LFER method provides a very useful tool to construct a predictive model for human skin 
permeability of neutral molecules, ions and ionic species. In this study, an equation has been 
constructed using the experimental log Kp of a large and varied set of compounds and species. 
The equation can be used to predict the values of log Kp for neutral molecules, ions and ionic 
species. The PSD value of the equation is 0.432, which shows that log Kp can be predicted 
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quite accurately. An advantage of our method over previous methods is that it provides valid 
predictions of log Kp for partially ionized compounds, in terms of the fractions of neutral and 
ionic species that exist at some given pH of the donor solution. We found that for ionizable 
compounds at low degrees of ionization (that is, less than 50%), the experimental values of 
log Kp do not deviate markedly from that for the neutral molecules. By a critical analysis via 
LEERs, it was confirmed that the thickness of skin exerts very little influence on the 
experimental value of log Kp. 
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Legend to Figures 
Figure 1. Distribution of log Kp (cm/s) of the compounds and species in our data set. 
 
Figure 2. A plot of observed log Kp (cm/s) versus calculated log Kp (cm/s) for all the 
compounds and species involved in the calculation of Eq. 6. The solid line corresponds to ideal 
agreement. Markers: ○, neutral molecules; ■, cations from protonated bases; ♦, anions from 
deprotonated acids.  
 
Figure 3. A plot of values of log Kp (cm/s) for ketoprofen as a function of the pH of the donor 
solution. The value of Fi at the top axis corresponds to the ionic fraction of ketoprofen at given 
pH. ● calculated values, ○ observed values for the neutral and fully ionized forms.  
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